Sun Pharmaceutical Industries to acquire 16.7% shares in Lyndra Therapeutics, Inc

19 Dec 2023 Evaluate

Sun Pharmaceutical Industries has entered into agreement to acquire around 16.7% shares on fully diluted basis, in Lyndra Therapeutics, Inc., a company based in Massachusetts, engaged in the business of developing novel delivery technology for long-acting oral (LAO) therapies.

This strategic investment is to support development of innovative pharmaceutical delivery technologies and get access to the technology for certain molecules and territories. Cost of acquisition is $30 million. 

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1777.65 2.45 (0.14%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.